EMPLOYMENT AGREEMENTEmployment Agreement • March 19th, 2021 • Acutus Medical, Inc. • Surgical & medical instruments & apparatus • California
Contract Type FiledMarch 19th, 2021 Company Industry JurisdictionThis Employment Agreement (this “Agreement”) is made by and amongst Acutus Medical, Inc. (the “Company”), having its principal offices at 2210 Faraday Ave., Suite 100 Carlsbad, CA 92008, and David Roman (the “Executive”), effective as of March 1, 2021 (the “Effective Date”).
AMENDMENT NO. 2 AND WAIVERCredit Agreement • March 19th, 2021 • Acutus Medical, Inc. • Surgical & medical instruments & apparatus • New York
Contract Type FiledMarch 19th, 2021 Company Industry JurisdictionThis AMENDMENT NO. 2 AND WAIVER (this “Amendment”) is made and entered into as of October 21, 2020 by ORBIMED ROYALTY OPPORTUNITIES II, LP, in its capacity as Origination Agent and a Lender (each as defined in the Credit Agreement) under the Credit Agreement (as defined below) and DEERFIELD PRIVATE DESIGN FUND III, L.P., in its capacity as a Lender, in favor of ACUTUS MEDICAL, INC., a Delaware corporation (the “Borrower”) and acknowledged by WILMINGTON TRUST, NATIONAL ASSOCIATION, in its capacity as Administrative Agent (as defined in the Credit Agreement) under the Credit Agreement.
FIRST AMENDMENT TO CREDIT AGREEMENTCredit Agreement • March 19th, 2021 • Acutus Medical, Inc. • Surgical & medical instruments & apparatus • New York
Contract Type FiledMarch 19th, 2021 Company Industry JurisdictionThis FIRST AMENDMENT TO CREDIT AGREEMENT (this “Amendment”) is made and entered into as of June 7, 2019, by and among ACUTUS MEDICAL, INC., a Delaware corporation (the “Borrower”), orbimed royalty opportunities ii, lp, in its capacity as Origination Agent under the Credit Agreement (the “Origination Agent”) and orbimed royalty opportunities ii, lp in its capacity as a Lender under the Credit Agreement and Deerfield Private Design Fund III, L.P. (collectively, the “Lenders”), and acknowledged by Wilmington Trust, National Association (the “Administrative Agent”).